Obesity, Senescence, and Senolytics
Overview
Affiliations
Obesity is a major risk factor for the development of comorbidities such as type 2 diabetes, neurodegenerative disorders, osteoarthritis, cancer, cardiovascular and renal diseases. The onset of obesity is linked to an increase of senescent cells within adipose tissue and other organs. Cellular senescence is a stress response that has been shown to be causally linked to aging and development of various age-related diseases such as obesity. The senescence-associated-secretory phenotype of senescent cells creates a chronic inflammatory milieu that leads to local and systemic dysfunction. The elimination of senescent cells using pharmacological approaches (i.e., senolytics) has been shown to delay, prevent, or alleviate obesity-related organ dysfunction.
Obesity-associated Inflammation and Alloimmunity.
Zhou H, Gizlenci M, Xiao Y, Martin F, Nakamori K, Zicari E Transplantation. 2024; .
PMID: 39192462 PMC: 11868468. DOI: 10.1097/TP.0000000000005183.
Dole N, Betancourt-Torres A, Kaya S, Obata Y, Schurman C, Yoon J JCI Insight. 2024; 9(16).
PMID: 39171528 PMC: 11343608. DOI: 10.1172/jci.insight.175103.
Targeting Cell Senescence and Senolytics: Novel Interventions for Age-Related Endocrine Dysfunction.
Suda M, Paul K, Tripathi U, Minamino T, Tchkonia T, Kirkland J Endocr Rev. 2024; 45(5):655-675.
PMID: 38500373 PMC: 11405506. DOI: 10.1210/endrev/bnae010.
Kirchner V, Badshah J, Hong S, Martinez O, Pruett T, Niedernhofer L Transplantation. 2023; 108(7):1509-1523.
PMID: 37953486 PMC: 11089077. DOI: 10.1097/TP.0000000000004838.
"Bone-SASP" in Skeletal Aging.
Fang C, Liu B, Wan M Calcif Tissue Int. 2023; 113(1):68-82.
PMID: 37256358 PMC: 10230496. DOI: 10.1007/s00223-023-01100-4.